BTK-IN-44 (Compound 10) is a potent non-covalent inhibitor of Brutons tyrosine kinase (BTK) with an IC50 value of 24.7 nM. It disrupts signaling pathways in B-cell malignancies and demonstrates effective antitumor activity in lymphoma cells. BTK-IN-44 holds potential for research in B-cell malignancies, such as lymphoma.
Target:
BTK
* VAT and and shipping costs not included. Errors and price changes excepted
